Fingolimod Pharmacy Prior Authorization
Customize your policy alerts
Sign up for caresourcegeorgia Policy GA-MED-P-366579 alerts
Get alerted when Policy GA-MED-P-366579 changes without checking for updates manually.
Monitor payer policy activity
This policy governs CareSource Georgia Medicaid coverage and prior authorization for fingolimod products Gilenya and Tascenso ODT for relapsing forms of multiple sclerosis, subject to age, clinical, safety-monitoring, prescriber, dosing, and continuation-therapy requirements.
A baseline skin examination was added to the initial authorization criteria.
The requirement to discuss progressive multifocal leukoencephalopathy risk with the member before treatment was removed.
The policy was updated to include fingolimod as the generic policy name and Tascenso ODT as a covered product under the policy.
A 30-unit-per-30-day quantity limit and pediatric weight-based dosing were added to the policy.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.